Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

Alzheimer's disease 4 | 644
Cancer 4 | 2,346
Neuropathy 4 | 210
Pain agnosia 4 | 99
psoriasis 4 | 6,685
Allergic hypersensitivity disease 3 | 123
Asthma 3 | 349
Complex regional pain syndrome 3 | 12
Dermatitis 3 | 107
Huntington's disease 3 | 72
Hypertension 3 | 287
Parkinson's disease 3 | 364
Rhinitis 3 | 46
Schizophrenia 3 | 501
cystic fibrosis 3 | 1,665
diabetes mellitus 3 | 1,663
invasive ductal carcinoma 3 | 2,950
Amnesia 2 | 17
Angioedema 2 | 36
Anxiety disorder 2 | 22
Arthritis 2 | 248
Autonomic neuropathy 2 | 21
Bronchial Hyperreactivity 2 | 13
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Cystitis 2 | 16
Dementia 2 | 129
Diarrhea 2 | 155
Down syndrome 2 | 548
Endometriosis 2 | 535
Epicondylitis 2 | 19
Fibromyalgia 2 | 22
Hyperactive behavior 2 | 31
Hyperalgesia 2 | 71
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Irritable bowel syndrome 2 | 59
Lung Injury 2 | 20
Major Depressive Disorder 2 | 106
Migraine 2 | 79
Narcolepsy 2 | 58
Neurodegenerative disease 2 | 383
Neurogenic Inflammation 2 | 12
Pain disorder 2 | 13
Urticaria 2 | 53
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
facioscapulohumeral dystrophy 2 | 286
interstitial cystitis 2 | 2,299
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
ulcerative colitis 2 | 2,087
Acute diarrhea 1 | 2
Alcohol dependence 1 | 107
Anemia 1 | 252
Anxiety Disorders 1 | 37
Arthritis, Experimental 1 | 39
Autosomal dominant cerebellar ataxia 1 | 34
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Brain disease 1 | 83
Bronchitis 1 | 44
Charcot-Marie-Tooth disease 1 | 74
Chronic heart failure 1 | 46
Congestive heart failure 1 | 30
Constipation 1 | 43
Drug Eruptions 1 | 18
Eating disorder 1 | 24
Edema 1 | 38
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Glomerulonephritis 1 | 36
Hepatitis C 1 | 90
Hereditary Sensory and Autonomic Neuropathies 1 | 4
Heroin dependence 1 | 30
Hirschsprung's disease 1 | 42
Hypotension 1 | 53
Infarction, Middle Cerebral Artery 1 | 25
Kidney Failure, Chronic 1 | 45
Leiomyoma 1 | 25
Liver Cirrhosis, Experimental 1 | 108
Lupus erythematosus 1 | 80
Macroglobulinemia 1 | 17
Mammary Neoplasms 1 | 410
Nephrogenic adenoma 1 | 10
Nerve Degeneration 1 | 73
Osteoarthritis 1 | 96
Oxyphilic adenoma 1 | 21
Pain 1 | 70
Pancreatitis 1 | 97
Parkinson Disease 1 | 102
Phaeochromocytoma 1 | 20
Sudden infant death syndrome 1 | 33
Tetanus 1 | 66
Tularemia 1 | 22
axial spondyloarthropathy 1 | 28
chronic kidney disease 1 | 90
nervous system disorder 1 | 53
sarcoidosis 1 | 358

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01DK058007-04 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Beta-nerve growth factor NGF Tchem Non-IDG -3.99294 10626.8 510
Neprilysin MME Tclin Enzyme -3.60000 4179.2 1274
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Protachykinin-1 TAC1 Tbio Non-IDG -4.12709 13651.7 395